Company Financials

Middle East Healthcare Company Financials

Saudi riyal

business Middle East Healthcare Company Company Profile

Main Stock Listing

Tadawul: 4009

Market Capitalization SR3.03 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 8.08
Forward PE 8.81
Price to Sales TTM SR1.00
Price to Book MRQ SR1.65
Enterprise to Revenue 1.77
Enterprise to EBITDA 8.80

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 12.34%
Operating Margin 11.37%
Return on Assets TTM 4.81%
Return on Equity TTM 21.07%

Income Statement

Revenue TTM SR3,042,718,464
Revenue per Share TTM SR33.06
Quarterly Revenue Growth 5.00%
Gross Profit TTM SR1,145,850,496
EBITDA SR721,701,176
Net Income to Common TTM SR375,377,024
Diluted EPS TTM SR4.08
Quarterly Earnings Growth YoY -36.90%

Balance Sheet

Total Cash MRQ SR69,974,824
Total Cash per Share MRQ SR0.76
Total Debt MRQ SR
Total Debt to Equity MRQ 125.99
Current Ratio MRQ 1.54
Book Value per Share MRQ SR20.03

Cash Flow

Operating Cash Flow TTM SR665,619,776
Levered Free Cash Flow TTM SR-4,382,370

4009 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 92,040,000
Float Shares 40,810,536
Avg 10 Volume 1,046,476
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 55.66%
% Held by Institutions 4.32%

Stock Price Summary

Beta 0.04
Fifty Two Week Low SR31.72
Fifty Two Week High SR84.80
Fifty Two Week Change -109.35%
Day 50 MA SR40.72
Day 200 MA SR54.53

Dividends and Splits

Forward Annual Dividend Rate SR0.50
Forward Annual Dividend Yield 1.54%
Trailing Annual Dividend Rate SR0.50
Trailing Annual Dividend Yield 1.54%
Payout Ratio 12.25%
Dividend Date
Ex Dividend Date 2025-07-09
Last Split Factor
Last Split Date